¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Sartwell incubation model"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® incubation period, latent stage ÇÑ±Û Àẹ±â, ¹è¾ç±â°£
¼³¸í   
  1. º´¿øÃ¼°¡ Ã¼³»¿¡ Ä§ÀÔ(°¨¿°)ÇÑ ÈÄ ±×·Î ÀÎÇÑ °¨¿°ÁõÀÌ ¹ßº´ÇÒ ¶§±îÁöÀÇ ±â°£. º´¿øÃ¼ÀÇ Á¾·ù¿¡ µû¶ó ±× ³»¿ëÀÌ ´Ù¸£´Ù. ¿¹ÄÁ´ë ¸»¶ó¸®¾Æ´Â Ä§ÀÔÇÑ º´¿øÃ¼°¡ ÀÎü ³»¿¡¼­ ÀÏÁ¤ÇÑ ´Ü°è±îÁö ¹ßÀ°ÇÑ ÈÄ ¹ßº´Çϰí, ÀåÆ¼Çª½º´Â Ä§ÀÔÇÑ º´¿ø±ÕÀÌ ÀÏÁ¤ÇÑ ¼ö±îÁö ¹ø½ÄÀ» Çؾߠ¹ßº´Çϸç, ÆÄ»ódzÀº Ä§ÀÔÇÑ º´¿ø±ÕÀÌ »ý¼ºÇÑ µ¶¼Ò°¡ ³ú½Å°æ¿¡ ´ÞÇÑ ÈÄ¿¡ ¹ßº´ÇÑ´Ù. °°Àº º´À̶󵵠ħÀÔÇÑ º´¿øÃ¼ÀÇ ¾çÀ̳ª µ¶·Â, °¨¿°µÈ »ç¶÷ÀÇ °¨¼ö¼º µî¿¡ µû¶ó¼­µµ ´Þ¶óÁø´Ù. º¸Åë Àẹ±â¿¡´Â º´Àû Â¡Èİ¡ ³ªÅ¸³ªÁö ¾ÊÁö¸¸ ¹Î°¨ÇÑ »ç¶÷ÀÇ °æ¿ì´Â µÎÅë-½Ä¿åºÎÁø-Çö±âÁõ-ºÒÄè°¨°ú °°Àº Àü±¸Áõ»óÀ» ³ªÅ¸³»´Â ¼öµµ ÀÖ´Ù. 2. º¸¿Â±â°£, ¹è¾ç±â°£, ¹ßÀ°¿¡ ÇÊ¿äÇÑ ±â°£. 
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anaerobic incubation
    ¹«»ê¼Ò¹è¾ç, Çø±â¹è¾ç
  • extrinsic incubation period
    ¹Ù±ùÀẹ±â, ¿ÜÀẹ±â
  • incubation
    1. ¹è¾ç 2. ºÎ¶õ 3. º¸À°
  • incubation period
    Àẹ±â
  • incubation stage
    Àẹ±â
  • animal model
    µ¿¹°¸ðÇü
  • atomic model
    ¿øÀÚ¸ðÇü
  • additive model
    µ¡¼À¸ðµ¨
  • absolute risk model
    Àý´ëÀ§Çè¸ðÇü
  • bulk phase model
    µ¢¾î¸®À§»ó¸ðÇü
  • compartment model
    ±¸È¹¸ðµ¨
  • compartmentalization model
    ±¸È¹È­¸ðÇü
  • core conductor model
    ÇÙÀüµµÃ¼¸ðÇü
  • demonstration model
    ½Ã¹ü¸ðÇü
  • fluid mosaic model
    À¯µ¿¸ðÀÚÀÌÅ©¸ðµ¨
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • incubation period
    Àẹ±â
  • model
    ¸ðÇü, ¸ðµ¨
  • animal model
    µ¿¹°¸ðÇü
  • plaster model
    ¼®°í¸ðÇü
  • symmetry model
    ´ëĪÇü, ´ëμ³
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anaerobic incubation
    Çø±â¹è¾ç, ¹«»ê¼Ò¹è¾ç
  • extrinsic incubation period
    ¿ÜÀẹ±â, ¹Ù±ùÀẹ±â
  • incubation
    ¹è¾ç
  • incubation period
    Àẹ±â
  • incubation stage
    (¢¡incubation period) Àẹ±â
  • absolute risk model
    Àý´ëÀ§Çè¸ðÇü
  • additive model
    µ¡¼À¸ðµ¨
  • animal model
    µ¿¹°¸ðÇü
  • atomic model
    ¿øÀÚ¸ðÇü
  • bulk phase model
    µ¢¾î¸®À§»ó¸ðÇü
  • compartment model
    ±¸È¹¸ðµ¨
  • compartmentalization model
    ±¸È¹È­¸ðÇü
  • core conductor model
    ÇÙÀüµµÃ¼¸ðÇü
  • demonstration model
    ½Ã¹ü¸ðÇü
  • fluid mosaic model
    À¯µ¿¸ðÀÚÀÌÅ©¸ðµ¨
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ITE =in the ear model
    ±Í¼ÓÇü(º¸Ã»±â)
  • absolute risk model
    Àý´ëÀ§Çè¸ðµ¨
  • gnathostatic model
    ¾ÇŸðÇü(¡­Ù¼úþ).
  • health belief model
    °Ç°­¹ÏÀ½ ¸ðÇü.
  • homeostatic model
    Ç×»ó¼º ¸ðÇü(Ù¼úþ)<Ç¥ÁØÇü>
  • in-the-ear model
    ±Í¼ÓÇü(º¸Ã»±â)
  • plaster model
    ±é½º Çü(¡­úþ), ¼®°í ¸ðÇü.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anaerobic incubation
    Çø±â¼º ¹è¾ç
  • extrinsic incubation period
    ¿ÜÀẹ±â(ËíËöËÓË»).
  • incubation
    ¹è¾ç
  • incubation period
    Àẹ±â.¹Ì»ýº¸¿Â±â°£, ¹è¾ç±â°£.
  • incubation stage
    Àẹ±â(íÖÜÑÑ¢).
  • incubation stage
    Àẹ±â(ËöËÓË»).
  • incubation test
    º¸¿Â½ÃÇè(ÜÁè®ãËúÐ).
  • incubation ³ª incubatio
    º¸¿Â(ÜÁè®), ¹è¾ç(ÛÆå×).[ÀÇ]Àẹ(±â)(íÖÜÑ Ñ¢).[³»°ú]ºÎ¶õ(Ý¢Õ°).[»ýÈ­]Ç׿¹ÝÀÀ, Ç׿¹è¾ç.
  • incubation ³ª incubatio
    º¸¿Â(ÜÁè®), ¹è¾ç(ÛÆå×).ÀÇÀẹ(±â)(íÖÜÑ Ñ¢).³»°úºÎ¶õ(Ý¢Õ°).»ýÈ­Ç׿¹ÝÀÀ, Ç׿¹è¾ç, Ç׿Âó¸®.
  • absolute risk model
    Àý´ëÀ§Çè¸ðµ¨
  • atomic model
    ¿øÀÚ¸ðÇü(¡­Ù¼úþ).
  • biopsychological model
    »ýü½É¸®ÇÐÀû ¸ðµ¨
  • bulk phase model
    µ¢¾î¸® À§»ó ¸ðÇü
  • compartmentalization model
    ±¸È¹È­ ¸ðÇü
  • core conductor model
    ÇÙÀüµµÃ¼¸ðÇü(ú·ï³Óôô÷Ù¼úþ).
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • extrinsic incubation period
    ¸ð±â³»Àẹ±â
  • incubation period
    Àẹ±â
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • incubation
    Ç׿Âó¸®(ùöè®ô¥×â)
  • incubation mixture
    Ç׿Âó¸® È¥ÇÕ¹°(ùöè®ô¥×âûèùêÚª)
  • incubation period
    Àẹ±â(íÖÜÑÑ¢)
  • alternate-site model
    ±³´ëºÎÀ§(ÎßÓÛÝ»êÈ)¸ðÅÚ
  • asymmetric strand transfer model
    ºñ´ëĪ(ÞªÓßöà) °¡´ÚÀüÀÌ(ï®ì¹) ¸ðµ¨
  • ball and stick model
    °ø ¸·´ë ¸ðµ¨
  • Benson model
    º¥¼Õ ¸ðµ¨
  • bilayer model
    À̺ÐÀÚÃþ(ì£ÝÂí­öµ) ¸ðµ¨
  • breakage and reunion model
    Àý´ÜÀç°áÇÕ(ï·Ó¨î¢Ì¿ùê)¸ðµ¨
  • Britten-Davidson model
    ºê¸®Æ°-´ëºñ½¼ ¸ðµ¨
  • Cairns model
    Äɸ¥½º ¸ðµ¨
  • Campbell model
    Ä·º§ ¸ðµ¨
  • cloverleaf model
    Ŭ·Î¹öÀÙ ¸ðµ¨
  • concerted model
    Çùµ¿(úðÔÒ) ¸ðµ¨
  • CPK model
    CPK ¸ðµ¨
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • incubation
    º¸¿Â, ¹è¾ç, Àẹ±â, ºÎ¶õ, Ç׿¹ÝÀÀ, Ç׿¹è¾ç
  • incubation period
    Àẹ±â, º¸¿Â±â°£, ¹è¾ç±â°£
  • bulk phase model
    µ¢¾î¸®À§»ó¸ðÇü
  • compartmentalization model
    ±¸È¹È­¸ðÇü
  • general linear model
    ÀϹÝÀû ¼±Çü¸ðµ¨, ÀÏ¹Ý ¼±»ó¸ðµ¨
  • model
    ¸ðÇü, Ç¥ÁØÇü
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
IP Incubation Period; Àẹ±â
ICP incubation period; indwelling catheter program; infantile cerebral palsy; infection-control practiti...
IP icterus praecox; imaging plate; immune precipitate; immunoblastic plasma; immunoperoxidase technique...
MIP macrophage inflammatory protein; major intrinsic protein; maximum inspiratory pressure; maximum inte...
CPK cell population kinetic [model]; creatine phosphokinase
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
(125)I Incubation of
125I Incubation with
DI days of incubation
II incubation
CIGMA Continuous Infusion of Glucose with Model Assessment
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • model spray ¸ðÇü»ó¿¡ Ç¥½ÃÇÑ ¿¬ÇÊ ¼±ÀÌ Áö¿öÁöÁö ¾Ê°Ô Çϱâ À§ÇØ »ç¿ëµÇ´Â Àç·á.

    model trimmer

    ¸ðÇü ´Ùµë±â, ¸ðÇü »èÇÕ±â
    ¸ðÇüÀ» »èÁ¦ÇÏ¿© ÀÏÁ¤ÇÑ ±Ô°ÝÀ¸·Î Á¦ÀÛÇϱâ À§ÇØ »ç¿ëÇÏ´Â ±â±¸.
  • incubation period
    Àẹ±â, Àẹ ±â°£, º¸¿Â ±â°£, ¹è¾ç ±â°£
    1. ¹ßÀ°¿¡ ÇÊ¿äÇÑ ±â°£. 2. Àẹ±â. ¿øÀÎ ±ÕÀÌ Ã¼³»¿¡ ħÀÔÇÑ ¼ø°£ºÎÅÍ ½ÃÀÛÇÏ¿© ÁúȯÀÇ ÃÖÃÊÀÇ Áõ»óÀÌ ³ªÅ¸³¯ ¶§±îÁöÀÇ ±â°£.
  • biomedical model
    »ýÀÇÇÐÀû ¸ðµ¨
  • biopsychosocial model
    »ý¹° »çȸ ½É¸® ¸ðÇü
  • casting model
    ÁÖÁ¶ ¸ðÇü
    µ¿ÀǾî=refractoryc cast. ³³ÇüÀÌ ¸Å¸ôÁ¦¿¡ ÀÇÇØ ¸Å¸ôµÇ¾î ÀÖ´ø ºÎºÐÀ¸·Î ¸Å¸ôÁ¦¿¡ ÀÇÇØ Çü¼ºµÈ °ÍÀ¸·Î ÁÖÁ¶ ½Ã ¿ëÀ¶µÈ ±Ý¼ÓÀÌ Èê·¯ µé¾î°¥ ¼ö ÀÖ´Â ºó °ø°£À» ¸»ÇÑ´Ù.
  • computer simulation model
    ¸ðÀÇ ÄÄÇ»ÅÍ ¸ðÇü
  • conceptual model
    °³³äÀû ¸ðÇü
  • deletion model
    °á½Ç ¸ðµ¨
    µ¹¿¬º¯ÀÌÀÇ ÇϳªÀ̸ç À¯Àü ¹°ÁúÀÇ ÀϺκÐÀÌ °á¿©µÇ¾î ÀÖ´Â °Í. ¸é¿ª À¯ÀüÇп¡¼­´Â ¸é¿ª ±Û·ÎºÎ¸°ÀÇ H¼â À¯ÀüÀÚ±ºÀ» ÆÇµ¶ÇÏ´Â ±â±¸·Î¼­ÀÇ ´ë¸³ À¯ÀüÀÚ °á½Ç ¸ðµ¨ÀÌ À¯¸íÇÏ´Ù.
  • in the ear model
    ±Í¼ÓÇü
  • integrating conceptual model
    ÅëÇÕ °³³ä ¸ðÇü
  • model
    ¸ðµ¨, º»º¸±â, ¸ðÇü, Ç¥ÁØÇü
    Áø´ÜÇÐ ¶Ç´Â ÇØºÎÇÐ ¿¬±¸¿ëÀÇ ¸ðÇü°ú °°ÀÌ ´Ù¸¥ ¹°°ÇÀ» Ç¥ÇöÇÏ´Â °Í Ä¡°úÇп¡¼­ÀÇ ÁÖÇü Ç¥º».
  • model base
    ¸ðÇü Àú¸é
    ¸ðÇüÀÇ ¹Ø¸é.
  • model mounting
    ¸ðÇü ºÎÂø
    ÀÛ¾÷ ¸ðÇü°ú ´ëÇÕ Ä¡¿­ ¸ðÇüÀ» ±³Çձ⿡ ºÎÂø½ÃŰ´Â °úÁ¤.
  • model population
    ¸ðÇü Àα¸
  • MSV model

    MTD (ÃÖ´ë ³»¿ë·®

CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
short incubation hepatitis A virus disease with a short incubation period (usually 15 to 50 days), caused by hepatitis A virus, a member of the family Picornaviridae, often transmitted by faecal-oral route; may be inapparent, mild, severe, or occasionally fatal and occurs sporadically or in epidemics, commonly in school-age children and young adults; necrosis of periportal liver cells with lymphocytic and plasma cell infiltration is characteristic and jaundice is a common symptom.
Synonym: epidemic hepatitis, hepatitis A, infectious hepatitis, MS-1 hepatitis, short incubation hepatitis, virus A hepatitis.
(05 Mar 2000)
incubation <microbiology> The development of an infectious disease from the entrance of the pathogen to the appearance of clinical symptoms.
Origin: L. Incubatio
(13 Nov 1997)
incubation period <microbiology> The time from the moment of inoculation (exposure) to the development of the clinical manifestations of a particular infectious disease.
(13 Nov 1997)
incubation time <microbiology> The time from the moment of inoculation (exposure) to the development of the clinical manifestations of a particular infectious disease.
(13 Nov 1997)
extrinsic incubation period Time required for the development of a disease agent in a vector, from the time of uptake of the agent to the time when the vector is infective.
(05 Mar 2000)
long incubation hepatitis Outdated name for hepatitis B based on the longer incubation period (generally 30-180 days, usually 60-90) compared to hepatitis A (15-45 days, mean 30).
(05 Mar 2000)
Adair-Koshland-Nemethy-Filmer model <biochemistry, chemistry> A model to explain the allosteric form of cooperativity; in this model, in the absence of ligands, the protein exists in only one conformation; upon binding, the ligand induces a conformational change that may be transmitted to other subunits.
Synonym: Adair-Koshland-Nemethy-Filmer model, induced fit model.
(05 Mar 2000)
additive model A model in which the combined effect of several factors is the sum of the effects that would be produced by each of the factors in the absence of the others.
(05 Mar 2000)
age-structured model <epidemiology> A mathematical model which take into consideration the division of the host population into different age classes. Such models can used to consider the consequences of such factors as age-dependent infection, morbidity or mortality rates or of age-specific vaccination schedules.
(05 Dec 1998)
animal model Study in a population of laboratory animals that uses conditions of animals analogous to conditions of humans to simulate processes comparable to those that occur in human populations.
(05 Mar 2000)
Bingham model A model representing the flow behaviour of a Bingham plastic, in the idealised case.
(05 Mar 2000)
biomedical model A conceptual model of illness that excludes psychological and social factors and includes only biological factors in an attempt to understand a person's medical illness or disorder.
(05 Mar 2000)
biopsychosocial model A conceptual model that assumes that psychological and social factors must also be included along with the biological in understanding a person's medical illness or disorder.
(05 Mar 2000)
genetic model A formalised conjecture about the behaviour of a heritable structure in which the component terms are intended to have literal interpretation as standard structures of empirical genetics.
(05 Mar 2000)
mathematical model <epidemiology> A formal framework to convey ideas about the components of a host-parasite interaction. Construction requires three major types of information: (a) a clear understanding of the interaction within the individual host between the infectious agent and the host, (b) the mode and rate of transmission between individuals, and (c) host population characteristics such as demography and behaviour.
Mathematical models can aid exploration of the behaviour of the system under various conditions from which to determine the dominant factors generating observed patterns and phenomena. They also aid data collection and interpretation and parameter estimation, and provide tools for identifying possible approaches to control and for assessing the potential impact of different intervention measures.
(05 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • incubation
    ºÎÈ­
  • incubation
    ¾ËÀ» ǰÀ½;ºÎÈ­;ºÎÈ­±â°£;±âµµ;°èȹ;(º´¸®)Àẹ;Àẹ±â
  • model
    ¿øÇü
  • Model T
    ¹ß´Þ ÃʱâÀÇ;±¸½ÄÀÇ
  • computer model
    ÄÄÇ»ÅÍ ¸ðµ¨(½Ã¹Ä·¹ÀÌ¼Ç µî¿¡¼­ ½Ã½ºÅÛÀ̳ª ÇÁ·ÎÁ§Æ®ÀÇ ³»¿ë µ¿ÀÛÀ» ÇÁ·Î±×·¥È­ÇÑ °Í)
  • economic model
    (°æ)°æÁ¦ ¸ðµ¨
  • fashion model
    ÆÐ¼Ç ¸ðµ¨
  • floor model
    (Ź»óÇü¿¡ ´ëÇÏ¿©) ¸¶·çÇü;ÄܼÖÇü;(»óÁ¡ÀÇ) Àü½Ãǰ (±â±¸ µî)
  • macroeconomic model
    °Å½ÃÀû °æÁ¦ ¸ðµ¨
  • model
    ¸ðÇü;¿øÇü;º»;¼³°èµµ;¸ðµ¨;¸¶³×Ų;¸ð¹ü;¸ð¹üÀûÀÎ;¸ðÇüÀÇ;¸ð¾çÀ» ¸¶µé´Ù(Á¡Åä µûÀ§¸¦ ¾î¶² ÇüÀ¸·Î)¶ß´Ù;¼³°èÇÏ´Ù;...À» º»¶ß´Ù;model school ½Ã¹ý Çб³)
  • model builder
    °æÁ¦ ¸ðµ¨ÀÇ ÀÛ¼ºÀÚ
  • model building
    ¸ðµ¨ ±¸¼º
  • model(l)er
    ¸ðÇü(¼Ò»ó)À» ¸¸µå´Â »ç¶÷
  • role model
    ¿ªÇÒ ¸ðµ¨
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á